Tanzarella S; Lionello I; Valentinis B; Russo V; Lollini PL; Traversari C., Rhabdomyosarcomas are potential target of MAGE-specific immunotherapies., «CANCER IMMUNOLOGY, IMMUNOTHERAPY», 2004, 53, pp. 519 - 524 [Scientific article]
Giavazzi R; Aglietta M; Astolfi A; Falanga A; Fusco A; Labianca R; Lollini PL; Lombardo C; Natali PG; Pierotti MA; Presta M; Santoro M; Taraboletti G; Zupi G; Vecchio G, 45th annual meeting of the Italian Cancer Society. Bergamo, 9-12 November 2003, «TUMORI», 2004, 90, pp. 356 - 362 [Scientific article]
Scotlandi K.; Avnet S.; Benini S.; Manara M.C.; Serra M.; Cerisano V.; Perdichizzi S.; Lollini P.-L.; De Giovanni C.; Landuzzi L.; Picci P., Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells, «INTERNATIONAL JOURNAL OF CANCER», 2002, 101, pp. 11 - 16 [Scientific article]
Dall'Olio, F; Chiricolo, M; Lollini, P; Lau, J T, Human colon cancer cell lines permanently expressing alpha 2,6-sialylated sugar chains by transfection with rat beta-galactoside alpha 2,6 sialyltransferase cDNA, «BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS», 1995, 211, pp. 554 - 561 [Scientific article]
